Aiolos Bio
Sara Harmon is an experienced clinical operations professional currently serving as the Associate Director of Clinical Operations at Aiolos Bio since September 2023. Previously, Sara held the position of Expert Global Trial Manager at Novartis from January 2023 to October 2023, and has over four years of experience as a Senior Clinical Project Manager and Clinical Project Manager at Gyroscope Therapeutics. Early career roles include Consultant and Clinical Technician Manager at Georgia Eye Partners, along with significant regulatory responsibilities at Winship Cancer Institute of Emory University. Sara's clinical background includes certification as an Ophthalmic Technician while working at UCLA Health and Emory Healthcare, as well as a focus on pediatric ophthalmology at Thomas Eye Group. Educational qualifications include a Bachelor of Fine Arts from The University of Georgia, nursing studies at Georgia State University, and currently pursuing an Executive MBA from Quantic School of Business and Technology.
Aiolos Bio
At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immunological disorders. Our goal is to provide patients and caregivers with more efficacious therapies that significantly reduce treatment burden. Our vision is embodied in our current focus – the development of a groundbreaking anti-TSLP therapy with best-in-class potential. We are a San Francisco Bay area-based clinical stage biopharma company with additional operations in London, UK. The Aiolos team is comprised of seasoned drug developers, who have successfully developed and launched products for a range of immune conditions, including asthma, rheumatoid arthritis, IPF, and more. As we grow, we will look to add like-minded individuals to our team - those committed to the goal of providing a meaningful difference in the lives of patients suffering from respiratory illnesses and other immune disorders.